Asian
Science Seminar ASS-1
Preferential Expression of Heparanase Protein Correlates with Early Invasion and
Progression of Oral Mucosal Melanoma
Rosario Santos Rivera1, 2, Hitoshi
Nagatsuka2, Ryo Tamamura2, Jing
Xiao2, 3 and Noriyuki Nagai2
1College of Dentistry, University of the East,
3Department of Oral Pathology,
Oral
mucosal melanoma (OMM) is an aggressive tumor with frequent metastasis. Most OMMs begin with an in
situ phase and then progressed to invasive phase. Heparanase
is an endo-beta-D-glucuronidase, which cleaves heparan sulfate (HS) chains found in basement membrane (BM)
and extra-cellular matrix (ECM). Heparanase released
by invading neoplastic cells removes HS chains from
the BM resulting to increased permeability. The expression of heparanase has been studied in various neoplasms
and its expression has been related to invasion, progression, angiogenesis and
metastasis. The objective of the study was to determine the immunohistochemical
expression of heparanase in normal oral mucosa, oral melanosis, primary OMM and those that metastasized to the
lymph nodes. Results revealed that the melanocytes in
normal mucosa and in oral melanosis were negative to heparanase. However, melanoma cells in in situ, invasive and metastatic OMM were
positive. A gradual increase in the expression was observed during the
transformation from in situ to
invasive phase and in the progression to early invasive phase. However, in
deeper tumor areas, heparanase was limited to
melanoma cells individually invading the ECM, near the vessels and at the
invasive fronts. Several tumor cells that metastasized to the lymph nodes also
expressed heparanase. In conclusion, heparanase was only expressed by melanoma cells and not by
normal melanocytes. Heparanase
expression was most intense during the transformation from in situ to invasive phase and in early invasive phase suggesting
its correlation with the early invasion and progression of OMM.